The treatment of pristane-induced lupus mice with RES may inhibit CD4+ T cells by triggering the silent mating type information regulator 2 homolog 1 (SIRT1) (Wang et al., 2014). The gene discussed is SIRT1; the disease is systemic lupus erythematosus.